Digitizing validation: a leap in productivity
Although the input lists this customer as an unnamed tier-one biotech, the fetched Kneat page itself explicitly names the customer as Biogen Inc. Biogen faced escalating validation demand from regulatory requirements and growth, with inefficient paper-based processes creating bottlenecks in document management, approvals, and cross-site visibility. Biogen implemented Kneat Gx globally, replacing paper systems with a scalable digital platform, standardizing processes across facilities and enabling real-time monitoring. Results: 100% productivity increase in output, 85% improvement in equipment-changeover efficiency, 60% reduction in cycle times, and up to 58% faster approval times. A Quality Assurance Engineer at Biogen said: 'Kneat eliminates frustrating clerical type paper-based activities and allows staff to apply their skills. It removes the chain that is the paper system.'
The customer is anonymised in Kneat’s own case study — not withheld by us.
Kneat is a paperless computer-system and process-validation platform — one of the two dominant players in digitizing the validation evidence GxP systems require before go-live.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Kneat on its own site — read the original case study on kneat.com ↗
Note: the fetched page names the customer as Biogen Inc., differing from the 'unnamed tier-one biotech' label in the input data -- reported as the page states it
Related use cases
- 01Merck Sharp & Dohme (MSD) reduced validation time by 50%
- 02Building a Leading-Edge Digital Validation Program From the Ground Up
- 03$500,000 Saved with Kneat eLogbooks
- 04Harmonization that works
- 05How Recipharm Advanced Bio transformed validation with Kneat Gx
- 06Douglas Pharma builds a data-driven future with Kneat Gx